Lyophilization
Shorten Time to Market with New Data-Driven Lyophilization Process
Jeff Tremain
AbbVie Contract Manufacturing
PAO-03-21-CL-07Mar 29, 2021
Clinical Trial Logistics
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
Mark Woolf
Catalent
PAO-03-21-CL-06Mar 22, 2021
Business Development
Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?
Pharma's Almanac
PAO-03-21-NI-02Mar 16, 2021
COVID-19 Impacts
Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?
Pharma's Almanac
PAO-03-21-NI-01Mar 16, 2021
Tissue Models
Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine
Liz Boazak, Ph.D.
Altis Biosystems
PAO-03-21-CL-01Mar 11, 2021
Facility Design
Cell Therapy Facility Design Synopsis: Horizontal vs. Vertical
Brian Peasley
IPS-Integrated Project Services, LLC
PAO-03-21-CL-02Mar 08, 2021
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Ron Laethem, Ph.D.
Altis Biosystems
PAO-02-21-CL-04Feb 18, 2021
Process Intensification
Factory of the Future Will Be a Convergence of Digital and Bioprocessing Technologies
Vikas Revankar
MilliporeSigma
PAO-02-21-CL-03Feb 17, 2021
Nitrosamine
Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations
Ulrich Reichert, M.D.R.A.
MilliporeSigma
PAO-02021-CL-05Feb 10, 2021
Chemistry, Manufacturing, and Controls
Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization
Matthew Rota; Lisa Caralli; Jim Spavins
Catalent
PAO-01-21-CL-05Feb 05, 2021
Cell Therapy
Economically Viable, Same-Day Autologous Cell Therapies
Gregory Frost, Ph.D.; Sid Kerkar, M.D.
EXUMA Biotechnology
PAO-01-21-CL-06Feb 04, 2021
Tissue Models
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
Bailey Zwarycz, Ph.D
Altis Biosystems
PAO-02-21-CL-01Feb 04, 2021
Process Development
Innovative Approach to Process Development
Gerhard Noessner, Ph.D.
Fareva
PAO-02-21-CL-02Feb 03, 2021
Gene Therapy
Beyond 2020: Looking into the Crystal Ball for Gene Therapy
Ratish Krishnan
MilliporeSigma
PAO-01-21-CL-03Feb 01, 2021
Tissue Models
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Bailey Zwarycz, Ph.D
Altis Biosystems
PA1081Jan 26, 2021
HPAPI
A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs
Daniela Kovats
Fareva
PAO-01-21-CL-01Jan 11, 2021
Cell Therapy
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
Catalent
PAO-12-20-CL-01Dec 16, 2020